14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 20 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of GIS.F
Powered by GPT-4o
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Gilead Sciences, Inc. stock downgraded from Hold/Accumulate to Sell Candidate after Friday trading session.
(Updated on Jun 14, 2024)

Sell candidate since Jun 14, 2024 PDF

The Gilead Sciences, Inc. stock price gained 2.03% on the last trading day (Friday, 14th Jun 2024), rising from 59.20€ to 60.40€. During the last trading day the stock fluctuated 4.35% from a day low at 58.44€ to a day high of 60.98€. The price has risen in 7 of the last 10 days and is up by 3.55% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 34 more shares were traded than the day before. In total, 2 thousand shares were bought and sold for approximately 115.00€ thousand.

The stock lies the upper part of a falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at 60.45€ will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -12.74% during the next 3 months and, with a 90% probability hold a price between 49.65€ and 52.75€ at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

GIS.F Signals & Forecast

A buy signal was issued from a pivot bottom point on Friday, May 31, 2024, and so far it has risen 3.55%. Further rise is indicated until a new top pivot has been found. Gilead Sciences, Inc. has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Gilead Sciences, Inc. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at 60.50€. On a fall, the stock will find some support from the short-term average at 59.61€. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Gilead Sciences, Inc. stock

Gilead Sciences, Inc. finds support from accumulated volume at 60.03€ and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the stock moved 2.54€ (4.35%) between high and low. For the last week, the stock has had daily average volatility of 2.06%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (GIS.F) For The Upcoming Trading Day Of Monday 17th

For the upcoming trading day on Monday, 17th we expect Gilead Sciences, Inc. to open at 59.94€, and during the day (based on 14 day Average True Range), to move between 59.37€ and 61.43€, which gives a possible trading interval of +/-1.03€ (+/-1.71%) up or down from last closing price. If Gilead Sciences, Inc. takes out the full calculated possible swing range there will be an estimated 3.42% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at 60.62€ (0.36%) than the support at 60.03€ (0.61%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Gilead Sciences, Inc. stock A Buy?

Gilead Sciences, Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.

Current score: -1.278 Sell Candidate Downgraded

Predicted Opening Price for Gilead Sciences, Inc. of Monday, June 17, 2024

Fair opening price June 17, 2024 Current price
59.94€ ( 0.762%) 60.40€

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for GIS.F

Fibonacci Support & Resistance Levels

Level Price
R3 62.48 3.44%
R2 61.51 1.84%
R1 60.91 0.84%
Price 60.40
S1 58.97 -2.37%
S2 58.37 -3.36%
S3 57.40 -4.97%

Accumulated Volume Support & Resistance Levels

Level Price
R3 67.22 11.29%
R2 62.18 2.95%
R1 60.62 0.364%
Price 60.40
S1 60.03 -0.613%
S2 59.79 -1.01%
S3 58.64 -2.91%

GIS Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Jun 14, 2024 Jun 14, 2024 Jun 27, 2024 0.720€ 0%
2 Mar 14, 2024 Mar 14, 2024 Mar 28, 2024 0.714€ 0%
3 Dec 14, 2023 Dec 14, 2023 Dec 28, 2023 0.750€ 0%
4 Sep 14, 2023 Sep 14, 2023 Sep 14, 2023 0.750€ 0%
5 Jun 14, 2023 Jun 14, 2023 Jun 14, 2023 0.750€ 0%

FAQ

What is the symbol for Gilead Sciences, Inc. Stock and on which exchange is it traded?
The symbol for Gilead Sciences, Inc. is GIS.F and it is traded on the FRA (Frankfurt Stock Exchange).

Should I buy or sell Gilead Sciences, Inc. Stock?
Gilead Sciences, Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.

How to buy Gilead Sciences, Inc. Stock?
Gilead Sciences, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Gilead Sciences, Inc. Stock.

What's the current price of Gilead Sciences, Inc. Stock?
As of the end of day on the Jun 14, 2024, the price of an Gilead Sciences, Inc. (GIS.F) share was 60.40€.

What is the 52-week high and low for Gilead Sciences, Inc. Stock?
The 52-week high for Gilead Sciences, Inc. Stock is 80.00€ and the 52-week low is 57.29€.

What is the market capitalization of Gilead Sciences, Inc. Stock?
As of the Jun 14, 2024, the market capitalization of Gilead Sciences, Inc. is 75.249B.

When is the next earnings date for Gilead Sciences, Inc.?
The upcoming earnings date for Gilead Sciences, Inc. is Aug 08, 2024.
Click to get the best stock tips daily for free!

About Gilead Sciences, Inc.

Gilead Sciences. Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of coronavirus disease 2019; and Epclusa, Harvoni, V... GIS.F Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT